Back to search

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Data up to Jan 2025

Published2001
Citations244
References30

Total Citations Per Year

Abstract

References (30)

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1995 • 1,039 citations

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

1996 • 1,023 citations

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

1991 • 1,013 citations

Breast Tumor Cell Lines From Pleural Effusions2

1974 • 973 citations

Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.

1986 • 870 citations

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

1998 • 811 citations

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

1999 • 602 citations

Mechanism of Action

2002 • 434 citations

Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

1987 • 434 citations

Bisphosphonates induce apoptosis in human breast cancer cell lines

2000 • 430 citations

Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.

1995 • 421 citations

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity

1997 • 408 citations

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.

1998 • 373 citations

Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298

2000 • 356 citations

Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

1997 • 349 citations

Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial

2001 • 346 citations

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

1996 • 306 citations

Bisphosphonates Induce Breast Cancer Cell Death In Vitro

2000 • 275 citations

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1998 • 265 citations

Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis

1999 • 253 citations

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1991 • 247 citations

Histopathological Evaluation of Apoptosis in Cancer

1998 • 245 citations

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1996 • 226 citations

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.

1998 • 218 citations

Chapter 3 Assays for DNA Fragmentation, Endonucleases, and Intracellular pH and Ca2+ Associated with Apoptosis

1995 • 128 citations

Bone resorption induced by a metastatic human melanoma cell line

1995 • 54 citations

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models

1999 • 53 citations

Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone

1992 • 35 citations

Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry

1998 • 30 citations

Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases

1997 • 13 citations

Cited By (0)

Loading...
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells… (2001) – PubMed | Metascience Observatory Explorer